LYMPHOPROLIFERATIVE DISORDERS
Clinical trials for LYMPHOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy takes on Epstein-Barr virus in patients with weak immune systems
Disease control OngoingThis study tests an experimental cell therapy called tabelecleucel in about 190 people with diseases caused by the Epstein-Barr virus (EBV). The treatment uses specially trained immune cells to attack EBV-infected cells. The main goal is to see if the therapy can shrink tumors or…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Could a stem cell transplant fix faulty T-Cells?
Disease control OngoingThis study tests whether a stem cell transplant from a healthy donor can safely treat people with T-cell problems that cause immune system issues. Participants receive chemotherapy and antibody therapy before the transplant to prepare their body. The goal is to see if the new imm…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
Engineered immune cells get a navigation system to hunt down lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with Hodgkin lymphoma or cutaneous T-cell lymphoma that has not responded to standard therapy or has returned. The treatment uses a patient's own immune cells (T cells) that are genetically modified to recognize and attack c…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Supercharged immune cells take aim at tough lymphomas
Disease control OngoingThis study is testing a new cell therapy for people with Hodgkin's or Non-Hodgkin's lymphoma that has come back or hasn't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and then infuse them back. The main go…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
Massive study aims to uncover root causes of blood cancers
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find the genetic causes of blood and bone marrow cancers, such as leukemia. Researchers will look for specific cell abnormalities that drive cancer growth. Up to 5,000 people with these cancers will provide samples for analysis. The goal is to develop more effe…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC